Literature DB >> 23543034

The Microbiological Profiles of Infected Prosthetic Implants with an Emphasis on the Organisms which Form Biofilms.

Anisha Fernandes1, Meena Dias.   

Abstract

BACKGROUND: In spite of the decreasing incidence of orthopaedic device related infections to 1%, nowadays, device-related infections still remain a diagnostic, therapeutic and cost -related problem. AIMS AND
OBJECTIVE: To record the common causative organisms and the contributing risk factors for orthopaedic device-related infections in a tertiary care teaching hospital.
METHODS: In a prospective study, fifty patients who underwent orthopaedic device implantation from Jan 2009 - June 2010 were enrolled; among them, 42 patients were complicated with infections. The demography, microbiological data, treatment and the outcome of each patient were recorded. STATISTICAL ANALYSIS: The data was analyzed in terms of frequency and percentage.
RESULTS: Of the 50 samples, 42(84%) were culture positive, while 8(16%) were cultures negative. The femur was the most commonly affected bone in both males (median age-37.1yrs) and females (median age-41.3 yrs). Staphylococcus aureus was the organism which was most commonly isolated and which caused biofilms, followed by non-fermenting, gram negative bacilli and Klebsiella spp. We reported the first case till date in the literature of Candida krusei PJI, to the best of our knowledge. No anaerobes were isolated. Tissue trauma, open fractures, post-operative surgical site infections and Diabetes mellitus were found to be the important risk factors. The biofilm forming organisms were commonly associated with polymicrobial infections and even an aggressive antibiotic therapy was often inadequate to eliminate the infections. A conservative surgical treatment was associated with treatment failures. Implant removal or replacement was required in most of the cases to eradicate the infection.
CONCLUSION: The most common bacteria which were isolated included Staphylococcus aureus, followed by Pseudomonas aeruginosa and Klebsiella. A majority of them are resistant to the commonly used antibiotics, leading to treatment failures which necessitated an implant removal.

Entities:  

Keywords:  Biofilm; Implant surgery; Prosthetic joint infection

Year:  2013        PMID: 23543034      PMCID: PMC3592278          DOI: 10.7860/JCDR/2013/4533.2732

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections.

Authors:  Sebastiano Leone; Silvio Borrè; Antonella d'Arminio Monforte; Gennaro Mordente; Nicola Petrosillo; Alberto Signore; Mario Venditti; Pierluigi Viale; Emanuele Nicastri; Francesco N Lauria; Giampiero Carosi; Mauro Moroni; Giuseppe Ippolito
Journal:  Int J Infect Dis       Date:  2010-09-16       Impact factor: 3.623

Review 2.  Prosthetic joint infections: update in diagnosis and treatment.

Authors:  Andrej Trampuz; Werner Zimmerli
Journal:  Swiss Med Wkly       Date:  2005-04-30       Impact factor: 2.193

3.  Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention.

Authors:  C M Brandt; W W Sistrunk; M C Duffy; A D Hanssen; J M Steckelberg; D M Ilstrup; D R Osmon
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

4.  Prophylactic antibiotics in hip fractures. A double-blind, prospective study.

Authors:  J W Burnett; R B Gustilo; D N Williams; A C Kind
Journal:  J Bone Joint Surg Am       Date:  1980-04       Impact factor: 5.284

5.  Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties.

Authors:  M J Spangehl; B A Masri; J X O'Connell; C P Duncan
Journal:  J Bone Joint Surg Am       Date:  1999-05       Impact factor: 5.284

Review 6.  New developments in diagnosis and treatment of infection in orthopedic implants.

Authors:  A F Widmer
Journal:  Clin Infect Dis       Date:  2001-09-01       Impact factor: 9.079

Review 7.  Diagnosis and treatment of infections associated with fracture-fixation devices.

Authors:  Andrej Trampuz; Werner Zimmerli
Journal:  Injury       Date:  2006-05       Impact factor: 2.586

Review 8.  [Orthopedic implant infection: prognostic factors and influence of long-term antibiotic treatment on evolution. Prospective study, 1992-1999].

Authors:  Joaquín Gómez; María Rodríguez; Víctor Baños; Lorenzo Martínez; M Antonia Claver; Joaquín Ruiz; Encarna Simarro; José Antonio Cánovas; Manuel Medina; Manuel Clavel
Journal:  Enferm Infecc Microbiol Clin       Date:  2003-05       Impact factor: 1.731

9.  Early infection after hip fracture surgery: risk factors, costs and outcome.

Authors:  C Edwards; A Counsell; C Boulton; C G Moran
Journal:  J Bone Joint Surg Br       Date:  2008-06

Review 10.  Pathogenic organisms in hip joint infections.

Authors:  Udo Geipel
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

View more
  23 in total

1.  Culture-independent pilot study of microbiota colonizing open fractures and association with severity, mechanism, location, and complication from presentation to early outpatient follow-up.

Authors:  Geoffrey D Hannigan; Brendan P Hodkinson; Kelly McGinnis; Amanda S Tyldsley; Jason B Anari; Annamarie D Horan; Elizabeth A Grice; Samir Mehta
Journal:  J Orthop Res       Date:  2014-01-03       Impact factor: 3.494

2.  Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections.

Authors:  R P Howlin; M J Brayford; J S Webb; J J Cooper; S S Aiken; P Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

3.  Molecular Determinants of the Thickened Matrix in a Dual-Species Pseudomonas aeruginosa and Enterococcus faecalis Biofilm.

Authors:  Keehoon Lee; Kang-Mu Lee; Donggeun Kim; Sang Sun Yoon
Journal:  Appl Environ Microbiol       Date:  2017-10-17       Impact factor: 4.792

4.  Thermal shock susceptibility and regrowth of Pseudomonas aeruginosa biofilms.

Authors:  Erica B Ricker; Haydar A S Aljaafari; Trigg M Bader; Bryce S Hundley; Eric Nuxoll
Journal:  Int J Hyperthermia       Date:  2018-03       Impact factor: 3.914

5.  Synergistic effects of heat and antibiotics on Pseudomonas aeruginosa biofilms.

Authors:  Erica B Ricker; Eric Nuxoll
Journal:  Biofouling       Date:  2017-10-17       Impact factor: 3.209

6.  Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants.

Authors:  Eliana Drenkard; Rhianna M Hibbler; D Alina Gutu; Alexander D Eaton; Amy L Silverio; Frederick M Ausubel; Bryan P Hurley; Lael M Yonker
Journal:  J Vis Exp       Date:  2018-05-04       Impact factor: 1.355

7.  Structures of the activator of K. pneumonia biofilm formation, MrkH, indicates PilZ domains involved in c-di-GMP and DNA binding.

Authors:  Maria A Schumacher; Wenjie Zeng
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-22       Impact factor: 11.205

8.  Positive autoregulation of mrkHI by the cyclic di-GMP-dependent MrkH protein in the biofilm regulatory circuit of Klebsiella pneumoniae.

Authors:  Jason W H Tan; Jonathan J Wilksch; Dianna M Hocking; Nancy Wang; Yogitha N Srikhanta; Marija Tauschek; Trevor Lithgow; Roy M Robins-Browne; Ji Yang; Richard A Strugnell
Journal:  J Bacteriol       Date:  2015-03-02       Impact factor: 3.490

9.  Specific Infectious Organisms Associated With Poor Outcomes in Treatment for Hip Periprosthetic Infection.

Authors:  Daniel J Cunningham; Joseph J Kavolus; Michael P Bolognesi; Samuel S Wellman; Thorsten M Seyler
Journal:  J Arthroplasty       Date:  2017-01-26       Impact factor: 4.757

10.  Two-stage exchange for PJI with co-existing cerclages for fracture: higher rates of early re-infections and difficult to treat microbes.

Authors:  Daniel Karczewski; Maximilian Müllner; Christian Hipfl; Carsten Perka; Michael Müller
Journal:  Arch Orthop Trauma Surg       Date:  2022-01-28       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.